Englewood Hospital and Medical Center

healthpayerintelligence | January 23, 2020

Centene and WellCare announced they have finalized a major health payer merger deal that will combine the two organizations into the largest health insurer by membership with more than 24 million covered individuals. The finalized merger deal follows 10 months after the March 2019 announcement saying Centene planned to acquire WellCare for $17.3 billion in cash and stock to bolster and diversify product offerings, increase sales, and have access to new markets which would enhance value-bas...

Health Technology

InVita Healthcare Technologies | January 19, 2022

InVita Healthcare Technologies, a leading software provider for complex medical, forensic and community care environments, announces its investment in Transplant Connect, the world's leading software provider for the donation and transplantation field. "We are truly excited by this investment from InVita," said John Piano, Founder, Chairman and CEO, Transplant Connect. "Through this investment, we'll be able to expand vital resources and capabilities and meani...

Health Technology

Noridian Healthcare Solutions | June 28, 2022

In order to evaluate and confirm provider ownership data in Medicare systems, Noridian Healthcare Solutions, LLC (Noridian), a pioneer in creating solutions for federal, state, and commercial health care programs, has joined forces with management consulting firm RELI Group. Noridian is working closely with RELI Group, the prime contractor, as the subcontractor to build a procedure that will guarantee information is correct and complies with Center for Medicare & Medicaid (CMS) approval s...

Healthcare Analytics

Carbon Health | December 01, 2022

In honor of National Diabetes Awareness Month in November, Carbon Health, a hybrid healthcare company that combines expert care with proprietary technology for easy everyday health, announces compelling new patient outcomes from its innovative diabetes program. To date, Carbon Health's diabetes program has helped two-thirds of its patients with uncontrolled diabetes achieve and maintain recommended glycemic targets, while patients with baseline A1c >9.0% in particular saw an impressive...